BioTrinity 2026

2026 marks the 20th edition of BioTrinity, OBN’s flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The two-day conference will feature an abundance of scientific showcase presentations from R&D companies at around the Series A stage, a packed business & investment track, targeted drop-in sessions, satellite sessions, sponsors exhibition, networking events, private partnering meetings and an entrepreneurial academic poster presentation. 

BioTrinity is attended by an ever-evolving audience of c.850 delegates, comprising a mix of early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and a broad range of valued service providers. Delegates attend from the UK, Europe the U.S, Japan, China, Australia and beyond, and the team welcome discussion with clusters to discuss their delegation requirements.